Content about Opioids

May 7, 2012
Purdue Pharma launches free educational resource to combat drug abuse

Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.

March 27, 2012
HIE, mobile technology dominate conversations at HIMSS

A few weeks ago, we joined some 37,000 of our closest friends for the Healthcare Information and Management Systems Society (HIMSS) annual conference. HIMSS is a cause-based, not-for-profit organization focused on providing global leadership for the optimal use of information technology (IT) and management systems for the betterment of health care.

March 8, 2012
Hyland's showcases adult cough-cold medicines at ECRM show

Hyland's has extended its Defend lineup of cough-cold products with a pair of adult cough syrups — Defend Cough & Cold and Defend Cough & Cold Night — last week at the ECRM Cough & Cold and Allergy EPPS.

February 15, 2012
Prescription drug monitoring programs: Keeping good drugs from going bad
Regulators, healthcare providers and the public at large have taken note of the rise in prescription drug substance abuse. A recent article titled "Oxycodone Prescriptions Rose Sharply" in the New York Times (1/11/2012) describes trends of double-digit percentage increases in the dispensing of certain narcotic based painkillers. And many states have, or will be, implementing prescription drug monitoring programs — also known as prescription monitoring programs — that track the physicians prescribing and the patients receiving controlled substances.
January 27, 2012
Watson, Mallinckrodt settle over generic painkiller

Watson Pharmaceuticals and Mallinckrodt have reached a settlement concerning a painkiller for which the former had sought Food and Drug Administration approval.

January 24, 2012
Oxecta now commercially available

A pain medication that utilizes Acura Pharmaceuticals' Aversion technology now is commercially available.

January 23, 2012
ReportersNotebook — Chain Pharmacy, 1/30/12

The Food and Drug Administration is streamlining the enrollment process for risk evaluation and mitigation strategies for a class of painkillers, the agency said.

January 9, 2012
Endo addresses possible short-term supply of Opana ER, other drugs

Endo Pharmaceuticals announced a short-term supply constraint of analgesic products, including Opana ER, due to the temporary shutdown of a manufacturing facility operated by Novartis Consumer Health.

January 3, 2012
FDA approves new REMS for fentanyl-based painkillers

The Food and Drug Administration is streamlining the enrollment process for risk evaluation and mitigation strategies for a class of painkillers, the agency said Tuesday.

December 22, 2011
Actavis, QRxPharma partner to sell MoxDuo IR

Drug maker Actavis is partnering with QRxPharma to sell what the former called a novel pain drug in the United States.

December 22, 2011
Pfizer announces Embeda post-market trial results

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

December 13, 2011
Report: New Wash. law cuts off patient access to painkillers

A new law in Washington state intended to curb accidental deaths related to opioid painkillers is having some adverse side effects, according to published reports.

December 12, 2011
FDA approves crush-resistant painkiller by Endo

The Food and Drug Administration has approved a new formulation of a painkiller made by Endo Pharmaceuticals designed to thwart drug abuse, Endo said Monday.

December 12, 2011
FDA approves painkiller made by Sun Pharmaceutical Industries

The Food and Drug Administration has approved a generic painkiller made by Sun Pharmaceutical Industries, Sun said.

November 21, 2011
Impax Labs looks to market generic cancer pain drug

Drug maker Impax Labs is looking to challenge the patent protection on a drug used to treat pain related to cancer, the company said Monday.

November 15, 2011
Actavis launches Kadian authorized generic

Actavis has launched an authorized generic drug for treating pain, the company said.

November 11, 2011
Watson launches generic painkiller

Watson Pharmaceuticals has launched its generic version of an opioid drug for treating pain, the company said Thursday.

November 8, 2011
Purdue Pharma launches RxPATROL Twitter feed

Purdue Pharma has launched a new way for fighting pharmacy crime, the drug maker said Tuesday.

October 31, 2011
J&J submits new FDA application for Nucynta ER

A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

October 27, 2011
Mylan gets green light for MS Contin generic

Mylan has received final approval from the Food and Drug Administration for a drug designed to treat moderate to severe pain.

October 17, 2011
Archimedes Pharma launches Lazanda for breakthrough cancer pain

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

October 10, 2011
FTC clears Teva-Cephalon acquisition deal

The Federal Trade Commission has given Teva Pharmaceutical Industries the green light to acquire Frazer, Pa.-based drug maker Cephalon, but with some restrictions, Teva said.

October 7, 2011
Watson files for approval of generic painkiller

Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.

October 4, 2011
Amneal launches generic Felbatol

Amneal last month launched its version of an epilepsy treatment.

September 9, 2011
FDA approves Mylan allergy treatment

The Food and Drug Administration has approved a generic drug made by Mylan for treating allergies.

© 2012 Drug Store News. All Rights Reserved.